BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2078064)

  • 1. [Diagnosis and follow-up of superficial bladder tumors using non-invasive techniques].
    Zuloaga Gómez A; Luis Ortiz J; Nogueras Ocaña M; Fernández Mena J; Martínez Torres JL
    Arch Esp Urol; 1990; 43 Suppl 1():21-3. PubMed ID: 2078064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors].
    Pegoraro C; Bondavalli C; Molani L; Capitanio A; Schiavon L; Dall'Oglio B; Luciano M; Negri S
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():127-9. PubMed ID: 1836650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
    Cariou G; Maaraoui N; Cortesse A
    Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study.
    Nisman B; Yutkin V; Peretz T; Shapiro A; Barak V; Pode D
    Anticancer Res; 2009 Oct; 29(10):4281-5. PubMed ID: 19846987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alternatives to the cystoscopic control of bladder neoplasms].
    Páez Borda A; Luján Galán M; Martín Osés E; Berenguer Sánchez A
    Arch Esp Urol; 1997 Dec; 50(10):1079-83. PubMed ID: 9494196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
    Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
    Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of urinary cytology in the detection of recurrent bladder tumours.
    Baltaci S; Süzer O; Ozer G; Bedük Y; Göğüş O
    Int Urol Nephrol; 1996; 28(5):649-53. PubMed ID: 9061424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urine cytology and urine markers. Significance for clinical practice].
    Tritschler S; Zaak D; Knuechel R; Stief CG
    Urologe A; 2006 Nov; 45(11):W1441-7; quiz W1448. PubMed ID: 17063350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transabdominal ultrasonography and urinary cytology in the follow-up of superficial bladder tumors].
    Miján Ortiz JL; Zuluaga Gómez A; Martínez Torres JL; Puebla Ceverino M; Navarro Sánchez A
    Actas Urol Esp; 1988; 12(5):411-4. PubMed ID: 3064562
    [No Abstract]   [Full Text] [Related]  

  • 13. [The BTA stat test in the follow-up for bladder cancer].
    Gutiérrez Baños JL; Martín García B; de Diego Rodríguez E; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; del Valle Schaan JI; Roca Edreira A; Rado Velázquez MA
    Arch Esp Urol; 1999 Oct; 52(8):856-61. PubMed ID: 10589117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of modern ultrasonographic techniques in the follow up of patients with superficial bladder carcinoma.
    Stamatiou K; Moschouris H; Papadaki M; Perlepes G; Skolarikos A
    Med Ultrason; 2011 Jun; 13(2):114-9. PubMed ID: 21655537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ultrasonography and urinary cytology in diagnosing recurrence of superficial urinary bladder cancer compared to cystoscopy.
    Roy MK; Islam MF; Kibria SA
    Bangladesh Med Res Counc Bull; 2001 Apr; 27(1):23-32. PubMed ID: 11692897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
    Trenti E; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Pycha A; Kafka M; Degener S; Danuser H; Roth S; Pycha A
    Cancer Cytopathol; 2019 Jul; 127(7):465-469. PubMed ID: 31154670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert
    Cowan B; Klein E; Jansz K; Westenfelder K; Bradford T; Peterson C; Scherr D; Karsh LI; Egerdie B; Witjes A; Trainer A; Harris R; Goldfarb B; Flax S; Kroeger R; Boyd B; Liao J; Patel S; Bridge J; Reuter V; Quigley N; Brown S; Zhao S; Satya M; Bates M; Simon IM; Campbell S; Lotan Y
    BJU Int; 2021 Dec; 128(6):713-721. PubMed ID: 33793062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive molecular detection of bladder cancer recurrence.
    Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
    Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.